FLINT, Mich.— Diplomat Pharmacy announced financial results for the quarter ended March 31, 2018. All comparisons, unless otherwise noted, are to the quarter ended March 31, 2017. First Quarter 2018 Highlights include: • Revenue of $1,342 million, compared to $1,079 million, an increase of 24% • Specialty segment revenue of $1,153 million, compared to $1,079
FLINT, Mich. — Biosimilars, generic drugs and affordable branded drugs are top-of-mind at Diplomat Pharmacy Inc. this year as the specialty pharmacy looks to help health plans and patients rein in costs. According to Diplomat president Joel Saban, the surging market for expensive specialty drugs has put pressure on stakeholders across the health care sector.
FLINT, Mich. — Phil Hagerman, co-founder, chairman and chief executive officer of Diplomat Pharmacy Inc., the nation’s largest independent specialty pharmacy, plans to retire. Diplomat said Friday that board member Jeff Park has been named interim CEO, and independent lead director Ben Wolin has been appointed chairman. Both moves are effective immediately. Diplomat’s board has launched